Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants

Pediatrics

Volumn 123, Issue 4, 2009, Pages 1142-1146

  Janér, Joakim ^a   Andersson, Sture ^a   Kajantie, Eero ^a,b   Lassus, Patrik ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Angiogenesis; Bronchopulmonary dysplasia; Neonatal respiratory; Preterm infants

Indexed keywords

ENDOSTATIN;

ARTICLE; BIRTH; BIRTH WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; VERY LOW BIRTH WEIGHT; BLOOD; CHEMISTRY; FEMALE; FETUS BLOOD; MALE; NEWBORN; PREDICTION AND FORECASTING; PREMATURITY; STATISTICAL MODEL;

BRONCHOPULMONARY DYSPLASIA; ENDOSTATINS; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS;

EID: 65349105876     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1339     Document Type: Article

References (29)

1. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88(2):277-285 (Pubitemid 28015876)
2. Yamaguchi N, Anand-Apte B, Lee M, et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 1999;18(16):4414-4423 (Pubitemid 29391251)
3. Dhanabal M, Volk R, Ramchandran R, Simons M, Sukhatme VP. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun. 1999;258(2):345-352 (Pubitemid 29287054)
4. Dixelius J, Larsson H, Sasaki T, et al. Endostatin-induced tyrosine kinase signaling through the shb adaptor protein regulates endothelial cell apoptosis. Blood. 2000;95(11):3403-3411 (Pubitemid 30428470)
5. Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B. Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum. 2000;43(4):889-893
6. Noma H, Funatsu H, Yamashita H, Kitano S, Mishima HK, Hori S. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin. Arch Ophthalmol. 2002;120(8):1075-1080
7. May CA, Ohlmann AV, Hammes H, Spandau UH. Proteins with an endostatin-like domain in a mouse model of oxygen-induced retinopathy. Exp Eye Res. 2006;82(2):341-348 (Pubitemid 43122121)
8. Li Q, Olsen BR. Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am J Pathol. 2004;165(2):415-424 (Pubitemid 38971372)
9. Sertie AL, Sossi V, Camargo AA, Zatz M, Brahe C, Passos-Bueno MR. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (knobloch syndrome). Hum Mol Genet. 2000;9(13):2051-2058 (Pubitemid 30642670)
10. Janér J, Andersson S, Haglund C, Lassus P. Pulmonary endostatin perinatally and in lung injury of the newborn infant. Pediatrics. 2007;119(1). Available at: www.pediatrics.org/cgi/content/full/119/1/e241 (Pubitemid 46397831)
11. Abdollahi A, Hahnfeldt P, Maercker C, et al. Endostatin's antiangiogenic signaling network. Mol Cell. 2004;13(5):649-663 (Pubitemid 38368123)
12. Jia YH, Dong XS, Wang XS. Effects of endostatin on expression of vascular endothelial growth factor and its receptors and neovascularization in colonic carcinoma implanted in nude mice. World J Gastroenterol. 2004;10(22):3361-3364 (Pubitemid 39585483)
13. Akeson AL, Cameron JE, Le Cras TD, Whitsett JA, Greenberg JM. Vascular endothelial growth factor-A induces prenatal neovascularization and alters bronchial development in mice. Pediatr Res. 2005;57(1):82-88 (Pubitemid 40039897)
14. Compernolle V, Brusselmans K, Acker T, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med. 2002;8(7):702-710
15. Lassus P, Ristimaki A, Ylikorkala O, Viinikka L, Andersson S. Vascular endothelial growth factor in human preterm lung. Am J Respir Crit Care Med. 1999;159(5 pt 1):1429-1433 (Pubitemid 29227849)
16. National high blood pressure education program working group report on high blood pressure in pregnancy. Am J Obstet Gynecol. 1990;163(5 pt 1):1691-1712
17. Hyvönen K. Incidence and Screening of Gestational Diabetes [in Swedish]. Kuopio, Finland: University of Kuopio; 1991
18. Pihkala J, Hakala T, Voutilainen P, Raivio K. Characteristic of recent fetal growth curves in finland [in Finnish]. Duodecim. 1989;105(18):1540-1546
19. Kajantie E, Dunkel L, Turpeinen U, Stenman UH, Andersson S. Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight infants. Pediatr Res. 2006;59(4 pt 1):575-578 (Pubitemid 43740059)
20. Thompson RS, Trudinger BJ, Cook CM, Giles WB. Umbilical artery velocity waveforms: normal reference values for A/B ratio and pourcelot ratio. Br J Obstet Gynaecol. 1988;95(6):589-591 (Pubitemid 18156318)
21. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-1729 (Pubitemid 32578778)
22. Kajantie E, Raivio T, Janne OA, Hovi P, Dunkel L, Andersson S. Circulating glucocorticoid bioactivity in the preterm newborn after antenatal betamethasone treatment. J Clin Endocrinol Metab. 2004;89(8):3999-4003 (Pubitemid 39071506)
23. Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med. 2006;11(5):354-362 (Pubitemid 44038701)
24. Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol. 2000;279(3):L600-L607
25. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol. 2002;282(4):L811-L823 (Pubitemid 34665598)
26. Janér J, Andersson S, Haglund C, Karikoski R, Lassus P. Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development. Pediatrics. 2008;122(2):340-346
27. Bhandari V, Choo-Wing R, Lee CG, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006;12(11):1286-1293
28. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29(7):710-717 (Pubitemid 28322056)
29. Schwarz M, Lee M, Zhang F, Zhao J, Jin Y, Smith S, et al. EMAP II: a modulator of neovascularization in the developing lung. Am J Physiol Lung Cell Mol Physiol. 1999;276(2 pt 1):L365-L375 (Pubitemid 29102279)